ArticleUpdates in surgery2026
Survival prognostic impact of post-surgical complications in gastric cancer patients after neoadjuvant chemotherapy: a single western center analysis.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Improving Prognostic Stratification in Gastric Cancer: The Role of Lymph Node Staging Systems.Medicina (Kaunas, Lithuania) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIt's well known that postoperative complications (POC) negatively invalidate survival of patients who underwent surgery for gastric cancer (GC). Our study evaluates POC clinical impact in the prognosis of patients underwent neoadjuvant chemotherapy (NAC) for locally advanced Gastric Cancer (LAGC).
methodsWe enrolled 256 patients who underwent D2/D3 gastric resection in a curative way for LAGC. 50 patients underwent NAC according to FLOT scheme. Overall survival (OS) and Disease free survival (DFS) were investigated by univariate and multivariate analysis in NAC and non NAC patients.
resultsThere were 115 and 27 POC occurrences respectively in upfront surgery group and NAC one. 5 year-OS in upfront surgery patients was better in the arm without POC (59.1% vs. 52.1%), whereas 5 year-OS in NAC cohort was 81% and 79.7% for respectively patients with or without POC (p = 0.81, HR 1.196). 5y-OS strongly improved in patients with POC who underwent NAC rather than patients who underwent upfront surgery (81% vs 52.1%, respectively; p = 0.04, HR 2.186). DISCUSSION: NAC remains the gold standard treatment for patients with locally advanced GC and it could be a positive prognostic factor for patients with POC. We demonstrated that the negative POC impact was reduced by positive NAC effect. Prospective and larger studies need to build exact evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.